Phase 4Status unknown
Curcumin Therapy in Patients With Impaired Glucose Tolerance and Insulin Resistance
Antiatherogenic and Antimetabolic Effect of Curcumin Therapy in the Prevention and Delay of Type 2 Diabetic in Patients With Impaired Glucose Tolerance and Insulin Resistance
- Sponsor
- Srinakharinwirot University (Academic or other)
- Enrollment
- 200 planned
- Conditions
- Type 2 Diabetes; Pre-diabetes; Insulin Resistance; Cardiovascular Risk
- Interventions
- Curcumin
- Ages
- adults, older adults
- Registry
- NCT01052025
Full record on ClinicalTrials.gov
From the registry
The incidence rate of type 2 diabetes in Thai populations is high and increasing every year. Cardiovascular disease is the main complication of this disease, which has been defined as an important cause of death among Diabetic patients. This disease is now becoming a major health problem and causes a great economic loss to the country. Evidence shows that Curcumin, Thai herbal medicine, has the effectiveness of prevention and delay of type 2 diabetes. However, there is no scientific study that aims to prove the efficacy of this herb particularly for prevention and delay the disease in Patients with impaired glucose tolerance (pre-diabetes) and insulin resistance.
Primary outcomes
- To examine the efficacy of curcumin on the delay of degenerative beta-cells in pancrease for protection of Type 2 Diabetes in patients with impaired glucose tolerance (Pre-diabetes)
History
Study completion
Primary completion
Registered
Started
Papers citing this trial
- Curcumin extract for prevention of type 2 diabetes
Diabetes care